Shots:
- Ceva & Touchlight entered into an agreement & long-term collaboration for developing & manufacturing future animal health products, integrating the former’s development & marketing expertise with Touchlight’s dbDNA tech to develop DNA vaccines
- As per the agreement, Touchlight is entitled to upfront payment, development milestones & sales-based royalties, while the complete financial terms remain undisclosed
- Touchlight’s doggybone DNA or dbDNA technology utilizes a synthetic DNA vector allowing rapid, scalable & high purity production of DNA essential to the development of genetic medicines
Ref: Ceva| Image: Ceva & Touchlight
Related News:- PettureX Reports the Launch of AI Pet Health Scanner App, Addressing Pet Health
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
